Vivus Wins Its First Fda Drug Approval

The FDA approved a drug to treat erectile dysfunction from Vivus that would compete against Viagra, Cialis and Levitra.

Topics:  fda   vivus   viagra   cialis   levitra   drug   
YAHOO NEWS:
  • Regeneron's Eye Drug Eylea Wins Another FDA Approval
    Regeneron's Eye Drug Eylea Wins Another FDA Approval - Analyst Blog
    10/7/2014 - 5:34 pm | View Link
  • Regeneron's Eye Drug Eylea Wins Another FDA Approval
    Regeneron's (REGN) Eylea has received FDA approval for treating RVO patients.
    10/7/2014 - 3:30 pm | View Link
  • More
BING NEWS:
  • Healthcare Stock Insights: Vivus Wins FDA Diet Drug THUMBS UP, StemCells Give BACK
    Vivus Inc. (NASDAQ:VVUS) shares predictably jump, on word that the FDA okayed its weight-loss drug Qnexa/Qsymia on Wednesday, even though they has plummeted just before the announcement. At the same time, shares of Vivus’ competitors Arena ...
    07/18/2012 - 1:00 pm | View Link
  • Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
    Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ...
    07/17/2012 - 12:35 pm | View Link
  • Vivus Wins FDA Approval
    MINYANVILLE ORIGINAL Vivus (VVUS) shareholders got a piece of good news late last week when the Food and Drug Administration approved the ... a decision on market clearance in April but the FDA delayed doing so until July 17. "The majority of the value ...
    04/30/2012 - 12:40 pm | View Link
  • Vivus' Erectile Dysfunction Drug Stendra Wins FDA Approval
    The FDA approved Stendra, also known as avanafil, for prescription use for men suffering from erectile dysfunction on an as-needed basis at least 30 minutes before sexual activity. The drug's safety was established in three double-blind, placebo-controlled ...
    04/27/2012 - 2:00 pm | View Link
  • Vivus Obesity Pill Wins FDA Panel Nod; NeuroSearch Surges
    Trading in Vivus stock was halted yesterday before the FDA panel vote. NeuroSearch, which is developing tesofensine for obesity, climbed 5.6 percent to 17 kroner and Novo Nordisk, which is studying its Victoza diabetes drug as a weight-loss treatment ...
    02/23/2012 - 8:23 am | View Link
  • More
BING SEARCH:
  • VVUS Key Statistics
    Updated key statistics for VIVUS Inc. - including VVUS margins, P/E ratio, valuation, profitability, company description, and other stock analysis data.
    11/23/2014 - 7:24 pm | View Website
  • VVUS
    Up to date analysis of Vivus, Inc. (VVUS) and its stock by hedge fund managers and industry experts. Find out what Vivus, Inc. is saying about its business from the ...
    11/23/2014 - 6:59 am | View Website
  • VVUS Stock Quote
    Updated stock quote for VVUS - including VVUS stock price today, earnings and estimates, stock charts, news, futures and other investing data.
    11/22/2014 - 9:34 pm | View Website
  • Project FDA Report 5 | Stifling New Cures: The True Cost ...
    Avik Roy, Project FDA Report 5, April 2012. ... Stifling New Cures: The True Cost of Lengthy Clinical Drug Trials . Avik S. A. Roy, Senior Fellow, Manhattan Institute ...
    11/22/2014 - 7:22 am | View Website
  • Regeneron's Eye Drug Eylea Wins Another FDA Approval ...
    Good news flowed in at Regeneron Pharmaceuticals (REGN - Analyst Report) when the FDA cleared the company’s highly successful injectable eye drug for ...
    10/7/2014 - 3:58 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News